Yield10 Bioscience, Inc. (NASDAQ:YTEN) tinted loss of -1.39% (-0.02 points) to US$1.45. The volume of 0.12 Million shares climbed down over an trading activity of 763.13 Million shares. EPS ratio determined by looking at last 12 month figures is -2.77. Over the same time span, the stock marked US$8.67 as its best level and the lowest price reached was US$1.37. The corporation has a market cap of US$14.87 Million.
Yield10 Bioscience, Inc. (NASDAQ:YTEN)’s earnings per share has been growing at a -19.9 percent rate over the past 5 year when average revenue increase was noted as -53.1 percent. The return on equity ratio or ROE stands at -151.4 percent while most common profitability ratio return on investment (ROI) was -73.1 percent. The company’s institutional ownership is monitored at 9 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 0 percent gross margin.
Park City Group, Inc. (NASDAQ:PCYG) is worth US$147.11 Million and has recently fallen -1.39% to US$7.1. The latest exchange of 0.13 Million shares is below its average trading activity of 58.26 Million shares. The day began at US$7.05 but the price moved to US$7.05 at one point during the trading and finally capitulating to a session high of US$7.1. The stock tapped a 52-week high of US$15 while the mean 12-month price target for the shares is US$14.5.
Currently, the stock carries a price to earnings ratio of 60.17, a price to book ratio of 3.62, and a price to sales ratio of 7.04. For the past 5 years, the company’s revenue has grown 13.4%, while the company’s earnings per share has grown 24.8%. With an institutional ownership near 33.2%, it carries an earnings per share ratio of 0.12.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 2 brokerage firms polled by Factset Research. At present, 0 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 0 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 1.